Assessment of endothelial cell proliferation in primary breast carcinoma and its association with axillary lymph node status

Breast

Volumn 9, Issue 1, 2000, Pages 28-34

  Edel, M ^a   Robbins, P ^b   D'Antuono, M ^a   Harvey, J ^a   Papadimitriou, J ^a   Mitchell, C ^a   Dawkins, H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0034023149     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0082     Document Type: Article

References (33)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res. 46:1986;467-473.
2. Folkman J. What is the evidence that tumour growth is angiogenesis-dependent? J Natl Cancer Inst. 82:1990;4-6.
3. Weidner N. Tumour angiogenesis: review of current applications in tumour prognostication. Sem Diag Pathol. 10:1993;302-313.
4. Weidner N, Semple J P, Welch W R, Folkman J. Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
5. Weidner N, Folkman J, Pozza F. Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Nat Cancer Inst. 82:1992;1875-1887.
6. Bosari S, Lee AKC, DeLellis R A, Wiley B D, Heatley G J, Silverman M L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Path. 23:1992;755-761.
7. Horak E R, Leek R, Klenk N. Angiogenesis, assessed by platelet endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 340:1992;1120-1124.
8. Kaldjian E P, Jin L, Davenport R D, Lloyd R V. Immunohistochemical analysis of hormone receptors, tumour vascularity, and proliferative activity in paraffin-embedded sections of breast carcinoma tissues. Appl Immunohist. 1:1993;31-38.
9. Toi M, Kashitani J, Tominaga T. Tumour angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer. 55:1993;371-374.
10. Weidner N. Tumour vascularity as a prognostic factor in cancer patients - the evidence continues to grow. J Pathol. 184:1998;119-122.
11. Narita M, Nakao K, Ogino N, Nakahara M, Onishi A, Tsujimoto M. Independent prognostic factors in breast cancer patients. Am J Surg. 175:1998;73-75.
12. Martin L, Green B, Renshaw C. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer. 76:1997;1046-1054.
13. Hall N R, Fish D E, Goldin R D, Guillou P J, Monson J R T. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol. 1:1992;223-229.
14. Fox S B, Gatter K C, Bicknell R. Relationship of endothelial cell proliferation to tumour vascularity in human breast cancer. Cancer Res. 53:1993;4161-4163.
15. Axelsson K, Ljung B M, Moore D. Tumour angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Nat Cancer Inst. 87:1995;999-1007.
16. Goulding H, Rashid N F, Robertson J F. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Path. 26:1995;1196-1200.
17. Aranda F, Lagforga J B. Microvessel quantification in breast ductal invasive carcinoma. Path Res Pract. 192:1996;124-129.
18. Edel M J, Robbins P, Papadimitriou J. Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status. Breast Cancer Res Treat. 47:1998;17-27.
19. Singh Y, Nambu H, Yoshizawa K, Hatano T, Hioki K, Tsubura A. Factors related to axillary lymph node metastasis in T1 breast carcinoma. Oncol Rep. 5:1998;459-462.
20. Elston C W, Ellis I O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 19:1991;403-410.
21. Nagle R B, Witte M H, Martinez A P. Factor VIII - associated antigen in human lymphatic endothelium. Lymphology. 20:1987;20-24.
22. Jannink I, Bennen N, Blaauw J, Van Diest P, Baak J. At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients. Breast Cancer Res Treat. 36:1995;55-60.
23. Brown D C, Gatter K C. Monoclonal antibody Ki-67; its use in histopathology. Histopathology. 17:1990;489-503.
24. Rose D S C, Maddox P H, Brown D C. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J Clin Pathol. 47:1994;1010-1014.
25. Mazerolles C, Rishmann P, Chopin D. Usefulness of MIB1 monoclonal antibody in assessing proliferative index in human bladder carcinoma: comparison with Ki-67 antibody. Histopathology. 23:1994;563-568.
26. Hitchcock C L. Ki-67 staining as a means to simplify analysis of tumour cell proliferation (editorial). Am J Clin Path. 1993;444-445.
27. Cattoretti G, Becker M H G, Key G J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 168:1992;357-363.
28. Veronese S M, Gambacorta M. Detection of Ki-67 proliferation rate in breast cancer. Am J Clin Path. 95:1991;30-34.
29. Ostrowski M L, Chakraborty S, Laucirica R, Brown R, Greenberg D. Quantitative image analysis of MIB1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Anal Quant Cyt Hist. 17:1995;15-24.
30. Stephens M A. Use of the Kolmogorov-Smirnov, Cramer-von Mises and Related Statistics Without Extensive Tables. J Royal Stat Soc. 2:1970;115-122.
31. Jeltsch M, Kaipainen A, Joukov V. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425.
32. Vartanian R K, Weidner N. Correlation of intratumoural endothelial cell proliferation with microvessel density (tumour angiogenesis) and tumour cell proliferation in breast carcinoma. Am J Pathol. 144:1994;1188-1194.
33. Vartanian R, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation. Lab Invest. 73:1995;844-850.